1. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States, Public Health Service Task Force August 30, 2002

2. American Academy of Pediatrics, Guidelines for the Ethical Conduct of Studies to Evaluate

Drugs in Pediatric Populations (RE9503), Pediatrics, Volume 95, Number 2, Pevruary, 1995, Pages 286-294.

3. Sample Written Request for Drugs Indicated to treat HIV Infection, Mark Goldberger, Director, Office of Drug Evaluation IV.

4., Reduction of Maternal-Infant transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment., The New England Journal of Medicine, Volume 331, November 3, 1994, Number 18.

5., Safety of Antiretroviral Prophylaxis of Perinatal Transmission for HIV-Infected Pregnant Women and Their Infants, Lynne M. Mofenson and Paula Munderi, JAIDS, Volume 30, Number 2, June 1, 2002.

6. Can Perinatal HIV Infection aBe Eliminated in the United States?. , Lynne M. Mofenson., JAMA, August 11, 1999 - Vol 282, No. 6

7.Evaluation of a Regional Pilot Program to Prevent Mother-Infant HIV Transmission - Thailand, 1998-2000, MMWR, Bol 50, No. 28